Pharmaceuticals

G2/21 Update – Non-Binding Opinion Issued
The EPO’s highest court shares its initial thoughts about when data can be filed to support inventive step
Read More
14
Oct
2022
G 2/21 (ʺplausibilityʺ): update on recent events
What has happened since the questions were referred?
Read More
04
Aug
2022
IAM Patent 1000 rankings 2022
Carpmaels & Ransford is top ranked again for patent prosecution
Read More
13
Jul
2022
The impact of the Unified Patent Court and the Unitary Patent on SPCs
The biggest changes to the European patent system for a generation are finally around the corner – how will they affect SPCs?
Read More
22
Jun
2022
Patenting AI: Artificial intelligence and drug discovery
The challenges involved in protecting innovations in the drug design process at the EPO
Read More
16
Jun
2022
JUVE Patent UK rankings 2022
12 Carpmaels Partners and Senior Associates recommended in the rankings
Read More
06
Jan
2022
Carpmaels in Conversation: EPO Enlarged Board of Appeal special
Carpmaels in Conversation: Ep. 11 – EPO Enlarged Board of Appeal special: videoconferences and plausibility in inventive step
Read More
13
Dec
2021
Chambers & Partners 2022
New ranking in Life Sciences IP/Patent Litigation
Read More
21
Oct
2021
Who’s Who Legal 2021
12 Partners are listed in this year’s publication
Read More
04
Oct
2021
Legal 500 2022
31 Partners and Senior Associates ranked as leading practitioners
Read More
01
Oct
2021

Type

Service

Sector

Archive